NCT05544721View on ClinicalTrials.gov

A Study of Paravertebral Block in Thoracic Outlet Syndrome

PHASE4Enrolling by invitationINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions

Thoracic Outlet Syndrome

Interventions

DRUG

Ropivacaine

0.5% 3-4 mL per level, with levels T1 and T2 will be used as the block injectate

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER